Fresolimumab In Systemic Sclerosis

Clinical trial NCT01284322 · COMPLETED

Trial details

NCT number: NCT01284322
Sponsor: Boston University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Systemic Sclerosis

Start date: 2011-01-01
Primary completion: 2013-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.